When analyzing patients with breast cancer who received tamoxifen, those who had high levels of AIB1 protein or mRNA had a worse disease-free survival and higher incidence of tumor recurrence than those who had lower levels of AIB1 (101, 123). This evidence concerns the gene NCOA3 and breast carcinoma.